Sharon Hawkins

Sharon Hawkins

Board Member

Sharon Hawkins has lived in Minnesota since 2002 and has been active in several civic and philanthropic endeavors in the Twin Cities. In addition to serving on the Abbott Northwestern Hospital Foundation (ANWF) board, she is a member of the board of Twin Cities Rise, Charlemagne Institute, King Milling Company, Lake Minnetonka Garden Club, past member of MN Opera, and is founder and past president of the Middle School Schoolgirls’ Lacrosse Association.

She has served as gala chair and committee member for several charity benefits, including the Minneapolis Heart Institute Foundation, Children’s Heart Link, MN Opera, Twin Cities Rise, and ANWF. Sharon was an active volunteer at Blake and Breck Schools and is a past member of the parent advisory committee of Duke University, where her three children and son-in-law obtained degrees. Her hobbies include skiing, boating, golf, platform tennis, pickleball, biking, bridge and mahjong.

Back to Board of Directors

Sharon Hawkins
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.